Share Price and Basic Stock Data
Last Updated: October 15, 2025, 4:01 am
| PEG Ratio | -6.52 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sudarshan Chemical Industries Ltd operates in the dyes and pigments industry, with a current market capitalization of ₹10,314 Cr. The company’s stock price is ₹1,312, and it reported sales of ₹2,302 Cr for the fiscal year ending March 2023, which increased to ₹2,539 Cr in March 2024. The quarterly sales figures have shown a positive trend, with the latest reported sales of ₹764.24 Cr for March 2025, indicating strong growth compared to ₹691.18 Cr in March 2023. Despite fluctuations, such as the drop to ₹528.02 Cr in December 2022, the overall trajectory appears upward. Sudarshan’s operating profit margin (OPM) for the fiscal year 2025 is reported at 9.41%, while the operating profit for the same period is ₹381 Cr, underscoring its ability to generate profits amid fluctuating sales. The company has also diversified its revenue streams, contributing to a more resilient business model.
Profitability and Efficiency Metrics
The profitability metrics of Sudarshan Chemical reflect challenges and opportunities within the competitive landscape. The net profit for March 2023 stood at ₹45 Cr, which saw a significant increase to ₹357 Cr in March 2024, showcasing improved profit margins and operational efficiency. However, the reported return on equity (ROE) is relatively low at 3.07%, indicating that shareholder returns may not align with industry benchmarks. The company’s return on capital employed (ROCE) is similarly low at 6.03%. Interest coverage ratio has been strong at 9.04x, suggesting that Sudarshan can comfortably meet its interest obligations, but the cash conversion cycle (CCC) has extended to 353 days, indicating potential inefficiencies in working capital management. The net profit margin for March 2024 was reported at 14.07%, which reflects a robust improvement compared to previous years, thus enhancing its profitability profile.
Balance Sheet Strength and Financial Ratios
Sudarshan Chemical’s balance sheet shows a mix of strengths and vulnerabilities. Total borrowings increased significantly to ₹2,378 Cr by March 2025, compared to ₹467 Cr in March 2024, which raises concerns about leverage and financial risk. Despite this, the company’s reserves have grown impressively to ₹3,424 Cr, reflecting a solid equity base that can support future growth initiatives. The debt-to-equity ratio stands at 0.38, indicating moderate leverage relative to equity. Liquidity ratios also appear stable, with a current ratio of 1.38 and a quick ratio of 0.87, suggesting that the company can meet its short-term obligations, although the quick ratio indicates some reliance on inventory. The price-to-book value (P/BV) stands at 3.67x, which may suggest that the stock is trading at a premium compared to its book value, potentially reflecting market confidence in its growth prospects.
Shareholding Pattern and Investor Confidence
The shareholding structure of Sudarshan Chemical illustrates a diverse investor base, with promoters holding 16.41%, foreign institutional investors (FIIs) at 8.52%, domestic institutional investors (DIIs) at 23.51%, and the public holding 51.57%. This diverse distribution indicates a balanced approach to governance and investor engagement. However, promoter holdings have seen a decline from 35.82% in September 2022 to the current level, which may raise questions regarding insider confidence in the company’s future. Meanwhile, the number of shareholders has decreased to 64,728 in March 2025 from a peak of 75,946 in December 2022, indicating potential volatility in investor sentiment. The increase in DII holdings suggests institutional confidence, which could help stabilize stock prices amid market fluctuations.
Outlook, Risks, and Final Insight
If Sudarshan Chemical can sustain its recent profitability improvements and manage its working capital more efficiently, it may enhance shareholder value and attract further institutional investment. However, the significant increase in debt poses a risk that could affect its financial stability if not managed prudently. The company must also navigate competitive pressures in the dyes and pigments sector, which may impact margins. Furthermore, maintaining robust sales growth while controlling operational expenses will be crucial for sustaining its upward trajectory. As the financial landscape evolves, focusing on strategic growth initiatives and improving operational efficiencies will be vital for Sudarshan Chemical to solidify its market position and enhance long-term shareholder returns.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sudarshan Chemical Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 47.5 Cr. | 157 | 175/68.5 | 24.9 | 159 | 0.64 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 72.8 Cr. | 121 | 281/114 | 14.8 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 1,205 Cr. | 975 | 1,148/341 | 31.5 | 80.2 | 0.10 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,796 Cr. | 360 | 572/337 | 37.6 | 60.5 | 1.39 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 49.6 Cr. | 44.2 | 67.1/38.0 | 39.6 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,571.85 Cr | 352.00 | 35.65 | 185.85 | 0.36% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 627.15 | 554.16 | 528.38 | 528.02 | 691.18 | 608.11 | 600.68 | 565.75 | 764.24 | 633.62 | 696.09 | 666.43 | 1,349.44 |
| Expenses | 541.07 | 512.74 | 485.51 | 486.38 | 606.46 | 538.23 | 535.10 | 503.88 | 645.16 | 553.05 | 601.60 | 587.44 | 1,222.45 |
| Operating Profit | 86.08 | 41.42 | 42.87 | 41.64 | 84.72 | 69.88 | 65.58 | 61.87 | 119.08 | 80.57 | 94.49 | 78.99 | 126.99 |
| OPM % | 13.73% | 7.47% | 8.11% | 7.89% | 12.26% | 11.49% | 10.92% | 10.94% | 15.58% | 12.72% | 13.57% | 11.85% | 9.41% |
| Other Income | 1.71 | 0.84 | 1.42 | 0.99 | 1.54 | 319.24 | 5.69 | 4.28 | 2.99 | 3.50 | -6.19 | -26.34 | -38.33 |
| Interest | 5.46 | 6.06 | 9.34 | 11.02 | 15.05 | 10.31 | 9.63 | 8.58 | 8.38 | 7.03 | 8.88 | 11.41 | 20.96 |
| Depreciation | 24.80 | 25.80 | 26.95 | 30.91 | 30.56 | 34.60 | 35.42 | 35.48 | 35.67 | 35.93 | 36.61 | 36.55 | 57.14 |
| Profit before tax | 57.53 | 10.40 | 8.00 | 0.70 | 40.65 | 344.21 | 26.22 | 22.09 | 78.02 | 41.11 | 42.81 | 4.69 | 10.56 |
| Tax % | 22.37% | 31.92% | 43.25% | 17.14% | 19.85% | 22.44% | 31.88% | 33.91% | 25.61% | 28.39% | 30.13% | 89.13% | 97.06% |
| Net Profit | 44.66 | 7.08 | 4.54 | 0.58 | 32.57 | 266.96 | 17.86 | 14.59 | 58.03 | 29.43 | 29.90 | 0.51 | 0.31 |
| EPS in Rs | 6.45 | 1.02 | 0.66 | 0.08 | 4.70 | 38.56 | 2.58 | 2.11 | 8.38 | 4.25 | 4.32 | 0.07 | -0.52 |
Last Updated: August 1, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Sudarshan Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 1,349.44 Cr.. The value appears strong and on an upward trend. It has increased from 666.43 Cr. (Dec 2024) to 1,349.44 Cr., marking an increase of 683.01 Cr..
- For Expenses, as of Mar 2025, the value is 1,222.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 587.44 Cr. (Dec 2024) to 1,222.45 Cr., marking an increase of 635.01 Cr..
- For Operating Profit, as of Mar 2025, the value is 126.99 Cr.. The value appears strong and on an upward trend. It has increased from 78.99 Cr. (Dec 2024) to 126.99 Cr., marking an increase of 48.00 Cr..
- For OPM %, as of Mar 2025, the value is 9.41%. The value appears to be declining and may need further review. It has decreased from 11.85% (Dec 2024) to 9.41%, marking a decrease of 2.44%.
- For Other Income, as of Mar 2025, the value is -38.33 Cr.. The value appears to be declining and may need further review. It has decreased from -26.34 Cr. (Dec 2024) to -38.33 Cr., marking a decrease of 11.99 Cr..
- For Interest, as of Mar 2025, the value is 20.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.41 Cr. (Dec 2024) to 20.96 Cr., marking an increase of 9.55 Cr..
- For Depreciation, as of Mar 2025, the value is 57.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.55 Cr. (Dec 2024) to 57.14 Cr., marking an increase of 20.59 Cr..
- For Profit before tax, as of Mar 2025, the value is 10.56 Cr.. The value appears strong and on an upward trend. It has increased from 4.69 Cr. (Dec 2024) to 10.56 Cr., marking an increase of 5.87 Cr..
- For Tax %, as of Mar 2025, the value is 97.06%. The value appears to be increasing, which may not be favorable. It has increased from 89.13% (Dec 2024) to 97.06%, marking an increase of 7.93%.
- For Net Profit, as of Mar 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.51 Cr. (Dec 2024) to 0.31 Cr., marking a decrease of 0.20 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.52. The value appears to be declining and may need further review. It has decreased from 0.07 (Dec 2024) to -0.52, marking a decrease of 0.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,106 | 1,205 | 1,401 | 1,282 | 1,329 | 1,593 | 1,708 | 1,864 | 2,201 | 2,302 | 2,539 | 3,346 | 5,219 |
| Expenses | 974 | 1,075 | 1,232 | 1,093 | 1,139 | 1,386 | 1,460 | 1,574 | 1,923 | 2,088 | 2,220 | 2,962 | 4,726 |
| Operating Profit | 133 | 131 | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 318 | 383 | 493 |
| OPM % | 12% | 11% | 12% | 15% | 14% | 13% | 15% | 16% | 13% | 9% | 13% | 11% | 9% |
| Other Income | 2 | 23 | 14 | 25 | 15 | 81 | 22 | 7 | 5 | 5 | 332 | -67 | -38 |
| Interest | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 39 | 51 | 85 |
| Depreciation | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 141 | 166 | 229 |
| Profit before tax | 55 | 72 | 99 | 136 | 123 | 203 | 180 | 190 | 171 | 60 | 471 | 99 | 140 |
| Tax % | 37% | 24% | 29% | 25% | 31% | 33% | 20% | 26% | 24% | 25% | 24% | 39% | |
| Net Profit | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 357 | 60 | 86 |
| EPS in Rs | 5.08 | 7.86 | 10.10 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 | 51.63 | 7.10 | 9.88 |
| Dividend Payout % | 30% | 22% | 30% | 24% | 29% | 31% | 30% | 29% | 27% | 23% | 9% | 63% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 54.29% | 29.63% | 44.29% | -15.84% | 58.82% | 7.41% | -2.76% | -7.80% | -65.38% | 693.33% | -83.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | 14.66% | -60.13% | 74.67% | -51.42% | -10.17% | -5.04% | -57.58% | 758.72% | -776.53% |
Sudarshan Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -11% |
| 3 Years: | -18% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 46% |
| 1 Year: | 36% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: September 10, 2025, 2:34 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 |
| Reserves | 264 | 249 | 300 | 367 | 426 | 554 | 587 | 730 | 819 | 814 | 1,135 | 3,424 |
| Borrowings | 440 | 433 | 430 | 433 | 431 | 367 | 501 | 618 | 823 | 829 | 467 | 2,378 |
| Other Liabilities | 217 | 317 | 346 | 379 | 433 | 424 | 522 | 638 | 705 | 725 | 730 | 3,854 |
| Total Liabilities | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 |
| Fixed Assets | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1,126 | 1,102 | 2,958 |
| CWIP | 7 | 8 | 15 | 8 | 6 | 24 | 48 | 278 | 285 | 44 | 15 | 140 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 548 |
| Other Assets | 594 | 671 | 716 | 733 | 822 | 869 | 948 | 1,105 | 1,243 | 1,210 | 1,227 | 6,026 |
| Total Assets | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 |
Below is a detailed analysis of the balance sheet data for Sudarshan Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,424.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,135.00 Cr. (Mar 2024) to 3,424.00 Cr., marking an increase of 2,289.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2,378.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 467.00 Cr. (Mar 2024) to 2,378.00 Cr., marking an increase of 1,911.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,854.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 730.00 Cr. (Mar 2024) to 3,854.00 Cr., marking an increase of 3,124.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 9,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,346.00 Cr. (Mar 2024) to 9,672.00 Cr., marking an increase of 7,326.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,102.00 Cr. (Mar 2024) to 2,958.00 Cr., marking an increase of 1,856.00 Cr..
- For CWIP, as of Mar 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 140.00 Cr., marking an increase of 125.00 Cr..
- For Investments, as of Mar 2025, the value is 548.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 548.00 Cr., marking an increase of 546.00 Cr..
- For Other Assets, as of Mar 2025, the value is 6,026.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,227.00 Cr. (Mar 2024) to 6,026.00 Cr., marking an increase of 4,799.00 Cr..
- For Total Assets, as of Mar 2025, the value is 9,672.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,346.00 Cr. (Mar 2024) to 9,672.00 Cr., marking an increase of 7,326.00 Cr..
Notably, the Reserves (3,424.00 Cr.) exceed the Borrowings (2,378.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -307.00 | -302.00 | -260.00 | -244.00 | -240.00 | -160.00 | -253.00 | -328.00 | -545.00 | -616.00 | -149.00 | 381.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 |
| Inventory Days | 144 | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 507 |
| Days Payable | 63 | 94 | 96 | 139 | 126 | 94 | 139 | 152 | 150 | 136 | 132 | 288 |
| Cash Conversion Cycle | 166 | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 353 |
| Working Capital Days | 41 | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 154 |
| ROCE % | 14% | 16% | 19% | 22% | 18% | 17% | 18% | 17% | 13% | 6% | 11% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Axis Small Cap Fund | 2,440,688 | 0.72 | 133.99 | 2,440,688 | 2025-04-22 17:25:20 | 0% |
| Mirae Asset Midcap Fund | 1,788,333 | 0.71 | 98.18 | 1,788,333 | 2025-04-22 17:25:20 | 0% |
| ICICI Prudential Smallcap Fund | 1,540,140 | 1.19 | 84.55 | 1,540,140 | 2025-04-22 17:25:20 | 0% |
| Mirae Asset Multicap Fund | 252,997 | 0.63 | 13.89 | 252,997 | 2025-04-22 16:51:54 | 0% |
| Axis Multi Asset Allocation Fund | 195,318 | 0.87 | 10.72 | 195,318 | 2025-04-22 17:25:20 | 0% |
| Axis Children's Gift Fund Compulsory Lock-in - Regular Plan | 61,836 | 0.42 | 3.39 | 61,836 | 2025-04-22 17:25:20 | 0% |
| Axis Children's Gift Fund No Lock-in - Regular Plan | 61,836 | 0.42 | 3.39 | 61,836 | 2025-04-22 17:25:20 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 49,922 | 0.44 | 2.74 | 49,922 | 2025-04-22 17:25:20 | 0% |
| LIC MF Small Cap Fund | 900 | 0.03 | 0.05 | 900 | 2025-04-22 17:25:20 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 51.60 | 6.50 | 18.80 | 20.40 | 20.88 |
| Diluted EPS (Rs.) | 51.60 | 6.50 | 18.70 | 20.40 | 20.88 |
| Cash EPS (Rs.) | 72.03 | 22.97 | 31.67 | 32.88 | 31.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 165.99 | 119.64 | 120.36 | 107.41 | 86.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 165.99 | 119.64 | 120.36 | 107.41 | 86.79 |
| Revenue From Operations / Share (Rs.) | 366.74 | 332.50 | 317.92 | 269.28 | 246.76 |
| PBDIT / Share (Rs.) | 48.18 | 31.12 | 40.42 | 42.58 | 36.26 |
| PBIT / Share (Rs.) | 27.78 | 14.62 | 27.53 | 30.08 | 25.64 |
| PBT / Share (Rs.) | 67.97 | 8.63 | 24.72 | 27.50 | 26.06 |
| Net Profit / Share (Rs.) | 51.64 | 6.47 | 18.77 | 20.38 | 20.88 |
| NP After MI And SOA / Share (Rs.) | 51.64 | 6.47 | 18.77 | 20.38 | 20.88 |
| PBDIT Margin (%) | 13.13 | 9.35 | 12.71 | 15.81 | 14.69 |
| PBIT Margin (%) | 7.57 | 4.39 | 8.65 | 11.17 | 10.39 |
| PBT Margin (%) | 18.53 | 2.59 | 7.77 | 10.21 | 10.56 |
| Net Profit Margin (%) | 14.07 | 1.94 | 5.90 | 7.56 | 8.46 |
| NP After MI And SOA Margin (%) | 14.07 | 1.94 | 5.90 | 7.56 | 8.46 |
| Return on Networth / Equity (%) | 31.10 | 5.40 | 15.59 | 18.97 | 24.05 |
| Return on Capital Employeed (%) | 12.88 | 7.23 | 14.59 | 18.20 | 19.82 |
| Return On Assets (%) | 15.17 | 1.87 | 5.48 | 7.04 | 8.86 |
| Long Term Debt / Equity (X) | 0.16 | 0.54 | 0.44 | 0.41 | 0.37 |
| Total Debt / Equity (X) | 0.38 | 0.98 | 0.98 | 0.65 | 0.75 |
| Asset Turnover Ratio (%) | 1.07 | 0.87 | 0.90 | 0.96 | 1.04 |
| Current Ratio (X) | 1.38 | 1.17 | 1.13 | 1.20 | 1.18 |
| Quick Ratio (X) | 0.87 | 0.67 | 0.60 | 0.72 | 0.61 |
| Inventory Turnover Ratio (X) | 2.96 | 2.48 | 2.82 | 2.64 | 2.91 |
| Dividend Payout Ratio (NP) (%) | 9.87 | 77.31 | 31.95 | 0.00 | 58.91 |
| Dividend Payout Ratio (CP) (%) | 7.08 | 21.77 | 18.94 | 0.00 | 39.05 |
| Earning Retention Ratio (%) | 90.13 | 22.69 | 68.05 | 0.00 | 41.09 |
| Cash Earning Retention Ratio (%) | 92.92 | 78.23 | 81.06 | 0.00 | 60.95 |
| Interest Coverage Ratio (X) | 9.04 | 5.19 | 14.41 | 16.49 | 17.64 |
| Interest Coverage Ratio (Post Tax) (X) | 2.15 | 2.08 | 7.69 | 8.90 | 9.99 |
| Enterprise Value (Cr.) | 4605.33 | 3488.90 | 4384.53 | 4055.41 | 3025.30 |
| EV / Net Operating Revenue (X) | 1.81 | 1.52 | 1.99 | 2.18 | 1.77 |
| EV / EBITDA (X) | 13.81 | 16.19 | 15.67 | 13.76 | 12.05 |
| MarketCap / Net Operating Revenue (X) | 1.66 | 1.17 | 1.64 | 1.93 | 1.52 |
| Retention Ratios (%) | 90.12 | 22.68 | 68.04 | 0.00 | 41.08 |
| Price / BV (X) | 3.67 | 3.26 | 4.32 | 4.83 | 4.31 |
| Price / Net Operating Revenue (X) | 1.66 | 1.17 | 1.64 | 1.93 | 1.52 |
| EarningsYield | 0.08 | 0.01 | 0.03 | 0.03 | 0.05 |
After reviewing the key financial ratios for Sudarshan Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 51.60. This value is within the healthy range. It has increased from 6.50 (Mar 23) to 51.60, marking an increase of 45.10.
- For Diluted EPS (Rs.), as of Mar 24, the value is 51.60. This value is within the healthy range. It has increased from 6.50 (Mar 23) to 51.60, marking an increase of 45.10.
- For Cash EPS (Rs.), as of Mar 24, the value is 72.03. This value is within the healthy range. It has increased from 22.97 (Mar 23) to 72.03, marking an increase of 49.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 165.99. It has increased from 119.64 (Mar 23) to 165.99, marking an increase of 46.35.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 165.99. It has increased from 119.64 (Mar 23) to 165.99, marking an increase of 46.35.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 366.74. It has increased from 332.50 (Mar 23) to 366.74, marking an increase of 34.24.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 48.18. This value is within the healthy range. It has increased from 31.12 (Mar 23) to 48.18, marking an increase of 17.06.
- For PBIT / Share (Rs.), as of Mar 24, the value is 27.78. This value is within the healthy range. It has increased from 14.62 (Mar 23) to 27.78, marking an increase of 13.16.
- For PBT / Share (Rs.), as of Mar 24, the value is 67.97. This value is within the healthy range. It has increased from 8.63 (Mar 23) to 67.97, marking an increase of 59.34.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 51.64. This value is within the healthy range. It has increased from 6.47 (Mar 23) to 51.64, marking an increase of 45.17.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 51.64. This value is within the healthy range. It has increased from 6.47 (Mar 23) to 51.64, marking an increase of 45.17.
- For PBDIT Margin (%), as of Mar 24, the value is 13.13. This value is within the healthy range. It has increased from 9.35 (Mar 23) to 13.13, marking an increase of 3.78.
- For PBIT Margin (%), as of Mar 24, the value is 7.57. This value is below the healthy minimum of 10. It has increased from 4.39 (Mar 23) to 7.57, marking an increase of 3.18.
- For PBT Margin (%), as of Mar 24, the value is 18.53. This value is within the healthy range. It has increased from 2.59 (Mar 23) to 18.53, marking an increase of 15.94.
- For Net Profit Margin (%), as of Mar 24, the value is 14.07. This value exceeds the healthy maximum of 10. It has increased from 1.94 (Mar 23) to 14.07, marking an increase of 12.13.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 14.07. This value is within the healthy range. It has increased from 1.94 (Mar 23) to 14.07, marking an increase of 12.13.
- For Return on Networth / Equity (%), as of Mar 24, the value is 31.10. This value is within the healthy range. It has increased from 5.40 (Mar 23) to 31.10, marking an increase of 25.70.
- For Return on Capital Employeed (%), as of Mar 24, the value is 12.88. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 12.88, marking an increase of 5.65.
- For Return On Assets (%), as of Mar 24, the value is 15.17. This value is within the healthy range. It has increased from 1.87 (Mar 23) to 15.17, marking an increase of 13.30.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.54 (Mar 23) to 0.16, marking a decrease of 0.38.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.38. This value is within the healthy range. It has decreased from 0.98 (Mar 23) to 0.38, marking a decrease of 0.60.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.07. It has increased from 0.87 (Mar 23) to 1.07, marking an increase of 0.20.
- For Current Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 1.5. It has increased from 1.17 (Mar 23) to 1.38, marking an increase of 0.21.
- For Quick Ratio (X), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 23) to 0.87, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.96. This value is below the healthy minimum of 4. It has increased from 2.48 (Mar 23) to 2.96, marking an increase of 0.48.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 9.87. This value is below the healthy minimum of 20. It has decreased from 77.31 (Mar 23) to 9.87, marking a decrease of 67.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 7.08. This value is below the healthy minimum of 20. It has decreased from 21.77 (Mar 23) to 7.08, marking a decrease of 14.69.
- For Earning Retention Ratio (%), as of Mar 24, the value is 90.13. This value exceeds the healthy maximum of 70. It has increased from 22.69 (Mar 23) to 90.13, marking an increase of 67.44.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 92.92. This value exceeds the healthy maximum of 70. It has increased from 78.23 (Mar 23) to 92.92, marking an increase of 14.69.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 9.04. This value is within the healthy range. It has increased from 5.19 (Mar 23) to 9.04, marking an increase of 3.85.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.15. This value is below the healthy minimum of 3. It has increased from 2.08 (Mar 23) to 2.15, marking an increase of 0.07.
- For Enterprise Value (Cr.), as of Mar 24, the value is 4,605.33. It has increased from 3,488.90 (Mar 23) to 4,605.33, marking an increase of 1,116.43.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.81. This value is within the healthy range. It has increased from 1.52 (Mar 23) to 1.81, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 24, the value is 13.81. This value is within the healthy range. It has decreased from 16.19 (Mar 23) to 13.81, marking a decrease of 2.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.17 (Mar 23) to 1.66, marking an increase of 0.49.
- For Retention Ratios (%), as of Mar 24, the value is 90.12. This value exceeds the healthy maximum of 70. It has increased from 22.68 (Mar 23) to 90.12, marking an increase of 67.44.
- For Price / BV (X), as of Mar 24, the value is 3.67. This value exceeds the healthy maximum of 3. It has increased from 3.26 (Mar 23) to 3.67, marking an increase of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.17 (Mar 23) to 1.66, marking an increase of 0.49.
- For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.08, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sudarshan Chemical Industries Ltd:
- Net Profit Margin: 14.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.88% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 31.1% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.15
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.87
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 78.5 (Industry average Stock P/E: 35.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | 7th Floor, Eleven West Panchshil, Survey No. 25, Near PAN Card Club Road, Pune Maharashtra 411045 | grievance.redressal@sudarshan.com http://www.sudarshan.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep R Rathi | Chairman |
| Mr. Rajesh B Rathi | Managing Director |
| Mr. Ashish Vij | Whole Time Director |
| Mr. Anuj N Rathi | Non Exe.Non Ind.Director |
| Mr. Sanjay K Asher | Ind. Non-Executive Director |
| Mrs. Rathi F Forbes | Ind. Non-Executive Director |
| Mr. Dara N Damania | Ind. Non-Executive Director |
| Mr. Subramanian Padmanabhan | Ind. Non-Executive Director |
| Mr. Naresh T Raisinghani | Ind. Non-Executive Director |
| Mrs. Shubhalakshmi A Panse | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Sudarshan Chemical Industries Ltd?
Sudarshan Chemical Industries Ltd's intrinsic value (as of 14 October 2025) is 847.49 which is 32.58% lower the current market price of 1,257.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹9,881 Cr. market cap, FY2025-2026 high/low of 1,604/796, reserves of ₹3,424 Cr, and liabilities of 9,672 Cr.
What is the Market Cap of Sudarshan Chemical Industries Ltd?
The Market Cap of Sudarshan Chemical Industries Ltd is 9,881 Cr..
What is the current Stock Price of Sudarshan Chemical Industries Ltd as on 14 October 2025?
The current stock price of Sudarshan Chemical Industries Ltd as on 14 October 2025 is 1,257.
What is the High / Low of Sudarshan Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sudarshan Chemical Industries Ltd stocks is 1,604/796.
What is the Stock P/E of Sudarshan Chemical Industries Ltd?
The Stock P/E of Sudarshan Chemical Industries Ltd is 78.5.
What is the Book Value of Sudarshan Chemical Industries Ltd?
The Book Value of Sudarshan Chemical Industries Ltd is 438.
What is the Dividend Yield of Sudarshan Chemical Industries Ltd?
The Dividend Yield of Sudarshan Chemical Industries Ltd is 0.36 %.
What is the ROCE of Sudarshan Chemical Industries Ltd?
The ROCE of Sudarshan Chemical Industries Ltd is 6.03 %.
What is the ROE of Sudarshan Chemical Industries Ltd?
The ROE of Sudarshan Chemical Industries Ltd is 3.07 %.
What is the Face Value of Sudarshan Chemical Industries Ltd?
The Face Value of Sudarshan Chemical Industries Ltd is 2.00.